Abiopharma

🔍 Haire Robert Joseph (Executive)

Company: STEPAN CO (SCL)

Report Date: 2025-12-31

Detailed Transactions and Holdings:

• Acquired 1,891 shares of Common Stock at $47.205 per share (Direct)
  Date: 2025-12-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,482.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: H | nature_of_ownership: By ESOP II Trust | shares_owned_after: 90.27
• Sold 1,891 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-31 | Code: M | Expires: 2026-12-31 | Exercise: 2025-12-31 | equity_swap_involved: 0 | shares_owned_after: 1,892.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3
• Sold 574 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-31 | Code: F | Expires: 2026-12-31 | Exercise: 2025-12-31 | equity_swap_involved: 0 | shares_owned_after: 1,318.00 | transaction_form_type: 4 | Footnotes: F2, F4, F3

Footnotes:

• F1: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award.
• F2: Each RSU represents a contingent right to receive one share of Stepan Company common stock.
• F3: Vest ratably over two years beginning on the date shown.
• F4: Withholding of shares to satisfy tax liability on the vesting of RSUs.